A NOVEL APPROACH TO ASSESS THE DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF IMMUNOGLOBULIN A NEPHROPATHY (IGAN) PATIENTS IN A US REAL-WORLD SETTING

被引:0
|
作者
Przybysz, Raymond [1 ]
Mehta, Rina [1 ]
Tomas, Gisela Rovira [2 ]
Aldworth, Carolina [2 ]
Doherty, Jim [2 ]
Studer, Rachel [2 ]
机构
[1] Novartis Pharmaceut, E Hanover, NJ USA
[2] Novartis Pharma AG, Basel, Switzerland
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
MO273
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Symptom Burden Among Immunoglobulin A Nephropathy (IgAN) Patients in a US Real-World Setting
    Perkins, Robert M.
    Aldworth, Carolina A.
    Przybysz, Raymond
    Doherty, Jim P.
    Olson, Stephen W.
    George, Aneesh T.
    Das, Jaydeep
    Studer, Rachel
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 494 - 495
  • [2] Clinical and demographic characteristics of patients (pts) treated with vemurafenib in real-world setting
    Sadetsky, N.
    Corvino, F.
    Surinach, A.
    Goodman, G.
    MELANOMA RESEARCH, 2016, 26 : E42 - E42
  • [3] REAL-WORLD CLINICAL CHARACTERISTICS AND DISEASE MANAGEMENT OF IMMUNOGLOBULIN A NEPHROPATHY PATIENTS ACROSS THE UNITED STATES
    Abner, S.
    Bissell, M. C. S.
    Polakow, T.
    Baker, M. D.
    VALUE IN HEALTH, 2024, 27 (06) : S194 - S194
  • [4] Real-World Demographic and Clinical Characteristics of Patients Initiating Avatrombopag in the US: The Real-AVA Study
    Kolodny, Scott
    Oladapo, Abiola
    Vredenburg, Michael
    Jamieson, Brian
    Swallow, Elyse
    Goldschmidt, Debbie
    Zichlin, Miriam L.
    Lopez, Priscilla
    Davidson, Mikhail
    Yee, John
    BLOOD, 2022, 140 : 13150 - 13151
  • [5] Prevalence, Characteristics, and Clinical Burden among Patients with Overweight or Obesity and Established ASCVD in a US Real-World Setting
    Michalak, Wojciech
    Boame, Nana
    Zhao, Xin
    Lamarre, Neil
    Rava, Andrew
    Doan, Quan V.
    Faurby, Mads
    Hartaigh, Briain O.
    Fabricatore, Anthony
    Zhao, Zhenxiang
    DIABETES, 2024, 73
  • [6] Clinical and Humanistic Burden of IgAN in Adult Patients: A Global Real-World Survey
    Tang, Sydney C. W.
    Chen, Wei
    Aldworth, Carolina
    George, Aneesh Thomas
    Kattlun, Julia
    Tomas, Gisela Rovira
    Kroes, Michel
    Roccatello, Dario
    Przybysz, Raymond
    Smeets, Serge
    Golden, Keisha
    Garratt-Wheeldon, Jade
    Chatterton, Emma
    de Courcy, Jonathan
    Lafayette, Richard
    KIDNEY360, 2025, 6 (01): : 121 - 132
  • [7] Patients with Idiopathic Membranous Nephropathy: A Real-World Clinical and Economic Analysis of US Claims Data
    Nazareth, Tara A.
    Kariburyo, Furaha
    Kirkemo, Aaron
    Xie, Lin
    Pavlova-Wolf, Anna
    Bartels-Peculis, Laura
    Vaidya, Neel
    Sim, John J.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (09): : 1011 - +
  • [8] CLINICAL AND DEMOGRAPHIC CHARACTERISTICS OF PATIENTS REACHING A HIGH DAILY DOSE OF IDEGLIRA SIX MONTHS AFTER INITIATION IN A REAL-WORLD SETTING
    Prager, R.
    Price, H.
    Blueher, M.
    Fernandes, J.
    Moller, J. B.
    Schultes, B.
    VALUE IN HEALTH, 2018, 21 : S122 - S122
  • [9] LONG COVID: CLINICAL CHARACTERISTICS AND MANAGEMENT IN THE REAL-WORLD SETTING
    Althoff, A.
    Rasouliyan, L.
    Kumar, V
    Chang, S.
    Long, S.
    Mummert, A.
    VALUE IN HEALTH, 2023, 26 (12) : S299 - S299
  • [10] THE DIAGNOSTIC JOURNEY OF PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY: DATA ANALYSIS OF A REAL-WORLD SURVEY
    Kroes, Michel
    Smeets, Serge
    George, Aneesh Thomas
    Prieto, Luis
    Decourcy, Jonathan
    Garratt-Wheeldon, Jade
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I563 - I563